Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_3
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

not_yet_recruiting120%
completed240%
recruiting120%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
terminatedphase_3

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

NCT04076748
not_yet_recruitingphase_2

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

NCT06382389
recruitingnot_applicable

Efficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration

NCT06928740
completednot_applicable

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

NCT05007028
completedphase_2

EMONO for the Treatment of Peripheral Neuropathic Pain

NCT02957851

Clinical Trials (5)

Showing 5 of 5 trials
NCT04076748Phase 3

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

Terminated
NCT06382389Phase 2

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

Not Yet Recruiting
NCT06928740Not Applicable

Efficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration

Recruiting
NCT05007028Not Applicable

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

Completed
NCT02957851Phase 2

EMONO for the Treatment of Peripheral Neuropathic Pain

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5